Olfactory Ensheathing Glia Transplantation Combined With LASERPONCTURE® in Human Spinal Cord Injury: Results Measured by Electromyography Monitoring
Author: Bohbot, Albert
Source: Cell Transplantation, Volume 19, Number 2, 2010 , pp. 179-184(6)
Publisher: Cognizant Communication Corporation
Abstract:Preliminary results were measured by electromyography monitoring (electromyoscan) on three subjects suffering from spinal cord injury and who underwent a double therapy. The aim of this study was to evaluate regained voluntary activity below the injury in subjects who received a double therapy: 1) an olfactory ensheathing glia (OEG) transplantation using procedures developed by Dr. Hongyun Huang at the Xishan Hospital and Rehabilitation Centre, Beijing, China, and 2) LASERPONCTURE® developed by Albert Bohbot, Laboratoire de Recherches sur le LASERPONCTURE®, La Chapelle Montlinard, France. Materials uses were the LASERPONCTURE® device developed by Albert Bohbot; the PROCOMP5TM equipment with softwares BIOGRAPH INFINITI 5® and REHAB SUITETM; the sensors MYOSCAN-PROTM EMG (SA9401M-50) to record muscle activity, and FLEX/PROTM-SA9309M to record skin conductance were fixed on the skin. An infrared laser, whose frequencies and power settings cannot be disclosed due to its proprietary nature, was applied after an OEG injection performed according to Dr. Hongyun Huang's procedures. Three cases, two males and one female, were selected for this study. Presentation and comments of the graphs recordings of voluntary muscle activity below the injury are provided. This preliminary study suggests that the double therapy restores some voluntary muscle activity as measured by electromyography monitoring.
Document Type: Research Article
Affiliations: , La Chapelle Montlinard,
Publication date: 2010-02-01
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.